Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 33

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1
Chunk 33
---
 and facilities are being operated in compliance in all material respects with applicable environmental
and health and safety laws and regulations.

Human
Capital Management

As
of December 31, 2024, we had seven full-time employees. None of our employees are represented by labor unions or covered by collective
bargaining agreements.

We
believe that our future success will depend, in part, on our continued ability to attract, hire and retain qualified personnel. In particular,
we depend on the skills, experience and performance of our senior management and research personnel. We compete for qualified personnel
with other biotechnology, medical device, pharmaceutical and healthcare companies, as well as universities and non-profit research institutions.

We
provide competitive compensation and benefits programs to help meet the needs of our employees. In addition to salaries, these programs
include incentive compensation plan, pension, healthcare and insurance benefits, paid time off, and family leave, among others. We also
use targeted equity-based grants with vesting conditions to facilitate retention of personnel, particularly for our key employees.

The
success of our business is fundamentally connected to the well-being of our people. Accordingly, we are committed to the health and safety
of our employees and we consider our relations with our employees to be good.

Available
Information

We
maintain a corporate website at http://www.indaptusrx.com. The information contained on, or that can be accessed through, our website
is neither a part of nor incorporated into this Annual Report.

Copies
of our reports on Forms 10-K, Forms 10-Q and Forms 8-K, may be obtained, free of charge, electronically through our corporate website
at http://www.indaptusrx.com as soon as reasonably practicable after we file such material electronically with, or furnish to, the SEC.
Additionally, the SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding
issuers that file electronically with the SEC at www.sec.gov.

25

Item
1A. Risk Factors.

You
should carefully consider the factors described below, together with all of the other information contained in this Annual Report, including
the audited consolidated financial statements and the related notes included in this Annual Report beginning on page F-1, before deciding
whether to invest in our common stock. If any of the risks discussed below actually occur, our business, financial condition, operating
results and cash flows could be materially adversely affected. This could cause the trading price of our common stock to